NO20045192L - Prosess for fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-4H-karbazol-4-on - Google Patents

Prosess for fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-4H-karbazol-4-on

Info

Publication number
NO20045192L
NO20045192L NO20045192A NO20045192A NO20045192L NO 20045192 L NO20045192 L NO 20045192L NO 20045192 A NO20045192 A NO 20045192A NO 20045192 A NO20045192 A NO 20045192A NO 20045192 L NO20045192 L NO 20045192L
Authority
NO
Norway
Prior art keywords
methyl
carbazol
imidazol
tetrahydro
preparation
Prior art date
Application number
NO20045192A
Other languages
English (en)
Norwegian (no)
Inventor
Szabolcs Salyi
Csaba Szabo
Sandor Molnar
Erzsebet Meszaros Sos
Tivadar Tamas
Original Assignee
Teva Gyogyszergyar Reszvenytar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Reszvenytar filed Critical Teva Gyogyszergyar Reszvenytar
Publication of NO20045192L publication Critical patent/NO20045192L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO20045192A 2002-04-29 2004-11-26 Prosess for fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-4H-karbazol-4-on NO20045192L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37632302P 2002-04-29 2002-04-29
PCT/US2003/013221 WO2003093281A1 (fr) 2002-04-29 2003-04-29 Methode de preparation de 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one

Publications (1)

Publication Number Publication Date
NO20045192L true NO20045192L (no) 2005-01-28

Family

ID=29401332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045192A NO20045192L (no) 2002-04-29 2004-11-26 Prosess for fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-4H-karbazol-4-on

Country Status (19)

Country Link
US (2) US7098345B2 (fr)
EP (1) EP1499623B1 (fr)
JP (1) JP2005529142A (fr)
KR (1) KR20040104654A (fr)
CN (1) CN1665823A (fr)
AT (1) ATE364611T1 (fr)
AU (1) AU2003223764A1 (fr)
CA (1) CA2483566A1 (fr)
DE (1) DE60314400T2 (fr)
DK (1) DK1499623T3 (fr)
ES (1) ES2288606T3 (fr)
HR (1) HRP20041070A2 (fr)
IL (1) IL164904A0 (fr)
MX (1) MXPA04010846A (fr)
NO (1) NO20045192L (fr)
PL (1) PL373191A1 (fr)
PT (1) PT1499623E (fr)
WO (1) WO2003093281A1 (fr)
ZA (1) ZA200408934B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366150A1 (en) * 2000-10-30 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
CN1665803A (zh) * 2002-04-30 2005-09-07 特瓦药厂有限公司 新晶形的昂丹司琼及其制备方法、含有该新晶形的药物组合物以及用其治疗恶心的方法
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
EP1828141A4 (fr) * 2004-10-26 2009-04-01 Ipca Lab Ltd Procede monotope de preparation de l'agent antiemetique 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US4859662A (en) * 1986-11-28 1989-08-22 Glaxo Group Limited Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
CA2112487C (fr) * 1991-06-26 2003-04-15 James W. Young Methode et compositions pour le traitement des vomissements, des nausees et d'autres troubles a l'ondansetron optiquement pur r(+)
CA2106642C (fr) * 1992-10-14 2005-08-16 Peter Bod Derives de carbazolone et procede d'obtention
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
PL366150A1 (en) 2000-10-30 2005-01-24 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (fr) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Procédé de préparation de la 1,2,3,9-tétrahydro-9-méthyl-3-((2-méthyl-1H-imidazol-1-yl)-méthyl)-4H-carbazol-4-one
DE02703115T1 (de) 2001-01-11 2004-10-21 Teva Pharmaceutical Industries Ltd. Verbessertes verfahren zur herstellung von reinem ondansetronhydrochlorid-dihydrat
WO2003090730A1 (fr) 2002-04-25 2003-11-06 Generics [Uk] Limited Nouvelles formes cristallines de celecoxib et d'autres composes
CN1665803A (zh) * 2002-04-30 2005-09-07 特瓦药厂有限公司 新晶形的昂丹司琼及其制备方法、含有该新晶形的药物组合物以及用其治疗恶心的方法

Also Published As

Publication number Publication date
DK1499623T3 (da) 2007-10-08
PL373191A1 (en) 2005-08-22
DE60314400T2 (de) 2008-02-07
HRP20041070A2 (en) 2005-02-28
CN1665823A (zh) 2005-09-07
EP1499623A1 (fr) 2005-01-26
ZA200408934B (en) 2006-07-26
US7098345B2 (en) 2006-08-29
ATE364611T1 (de) 2007-07-15
ES2288606T3 (es) 2008-01-16
MXPA04010846A (es) 2005-01-25
CA2483566A1 (fr) 2003-11-13
KR20040104654A (ko) 2004-12-10
DE60314400D1 (de) 2007-07-26
WO2003093281A1 (fr) 2003-11-13
US20060252942A1 (en) 2006-11-09
PT1499623E (pt) 2007-08-10
US20050020655A1 (en) 2005-01-27
EP1499623B1 (fr) 2007-06-13
AU2003223764A1 (en) 2003-11-17
JP2005529142A (ja) 2005-09-29
IL164904A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
MX2021005584A (es) Proceso para la preparación de (s)-nicotina de miosmina.
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
TW200626580A (en) Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
WO2003070725A3 (fr) Procede de preparation de derives de l'indolinone
EP1427411A4 (fr) (-)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions comprenant ce dernier et utilisations en tant qu'inhibiteur du recaptage de la dopamine
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
WO2002092564A3 (fr) Synthese de derives de cyclopentadiene
MX2022005229A (es) Un nuevo proceso eficaz para la sintesis de 2-amino-5-cloro-n,3-di metilbenzamida.
NO20045192L (no) Prosess for fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-4H-karbazol-4-on
Verrier et al. Highly diastereoselective addition of alkoxyethynyl aluminium reagents to N-tert-butylsulfinyl aldimines
MY152557A (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators
WO2021076835A8 (fr) Procédés de préparation d'acide 5-bromo-2-(3chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylique
WO2004026267A3 (fr) Produits de tri(alkylcarboxylato) gallium (iii) et compositions pharmaceutiques contenant ces produits
WO2008021491A3 (fr) Procédé de synthèse de 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
WO2004111047A3 (fr) Cycloalkanepyrrolopyridines utilisees comme antagonistes du recepteur dp
CA3156320A1 (fr) Derives de 2-azaspiro[3,4] octane utilises en tant qu'agonistes de m4
JOP20220084A1 (ar) مشتقات 5-أوكسا- 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4
MXPA05009725A (es) Derivados de ftalamida insecticidas.
TW200626555A (en) A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition
WO2008075163A3 (fr) Procédé perfectionné pour la fabrication de rizatriptan
CA2432138A1 (fr) Nouvelle methode de synthese de l'eletriptan
MX2009009232A (es) Nuevo procedimiento de preparacion de 3-metil-4-fenilsoxazolo [3,4-d]piridazin-7(6h)-ona.
WO2022115960A8 (fr) Dérivés d'aldéhyde et de cétone de psilocybine et leurs procédés d'utilisation
MX2022005415A (es) Compuesto de imidazolidinona, metodo de preparacion del mismo y uso del mismo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application